A new ocular melanoma genetic test reveals a patient’s prognosis with uncanny precision and cancer researchers say it is a taste of what may be coming as they continue to investigate the genes of cancer cells. Michael Birrer, HMS professor of medicine at Massachusetts General Hospital; Keith Flaherty, HMS associate professor of medicine at Massachusetts General Hospital; and Evangelos S. Gragoudas, the Charles Edward Whitten Professor of Ophthalmology at Massachusetts Eye and Ear Infirmary, are quoted.
